The Pharmacology of Acute Lung Injury in Sepsis
Author
Source
Advances in Pharmacological and Pharmaceutical Sciences
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-06-07
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Acute lung injury (ALI) secondary to sepsis is one of the leading causes of death in sepsis.
As such, many pharmacologic and nonpharmacologic strategies have been employed to attenuate its course.
Very few of these strategies have proven beneficial.
In this paper, we discuss the epidemiology and pathophysiology of ALI, commonly employed pharmacologic and nonpharmacologic treatments, and innovative therapeutic modalities that will likely be the focus of future trials.
American Psychological Association (APA)
Varisco, Brian Michael. 2011. The Pharmacology of Acute Lung Injury in Sepsis. Advances in Pharmacological and Pharmaceutical Sciences،Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-989844
Modern Language Association (MLA)
Varisco, Brian Michael. The Pharmacology of Acute Lung Injury in Sepsis. Advances in Pharmacological and Pharmaceutical Sciences No. 2011 (2011), pp.1-7.
https://search.emarefa.net/detail/BIM-989844
American Medical Association (AMA)
Varisco, Brian Michael. The Pharmacology of Acute Lung Injury in Sepsis. Advances in Pharmacological and Pharmaceutical Sciences. 2011. Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-989844
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-989844
